These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3966875)

  • 1. Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.
    Flint LM; Gott J; Short L; Richardson JD; Polk HC
    Arch Surg; 1985 Jan; 120(1):99-103. PubMed ID: 3966875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care.
    Niemiec PW; Allo MD; Miller CF
    Arch Surg; 1987 Feb; 122(2):207-12. PubMed ID: 3813869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic aminoglycoside monitoring in renal failure patients.
    Keller F; Borner K; Schwarz A; Offermann G; Lode H
    Ther Drug Monit; 1987 Jun; 9(2):148-53. PubMed ID: 3617152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia.
    Moore RD; Smith CR; Lietman PS
    Am J Med; 1984 Oct; 77(4):657-62. PubMed ID: 6385693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine.
    Tzovaras V; Tsimihodimos V; Kostara C; Mitrogianni Z; Elisaf M
    Nephrol Dial Transplant; 2011 Oct; 26(10):3219-24. PubMed ID: 21372252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patients.
    Wade WE; McCall CY
    Pharmacotherapy; 1995; 15(2):216-9. PubMed ID: 7624269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside therapy. Improving patient response and safety.
    Ackerman BH; Bailie GR; Zaske DE
    Postgrad Med; 1984 Feb; 75(2):177-86. PubMed ID: 6607465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC
    Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides use in patients over 75 years old.
    Fraisse T; Gras Aygon C; Paccalin M; Vitrat V; De Wazieres B; Baudoux V; Lechiche C; Vicens A; Sotto A; Pagani L; Gaillat J; Forestier E; Gavazzi G
    Age Ageing; 2014 Sep; 43(5):676-81. PubMed ID: 24590569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring aminoglycoside use in patients with severely impaired renal function.
    Noone P; Beale DF; Pollock SS; Perera MR; Amirak ID; Fernando ON; Moorhead JF
    Br Med J; 1978 Aug; 2(6135):470-3. PubMed ID: 354747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a university hospital in Saudi Arabia.
    Eltahawy AT; Bahnassy AA
    J Chemother; 1996 Aug; 8(4):278-83. PubMed ID: 8873833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring.
    De Waele JJ; De Neve N
    Minerva Anestesiol; 2014 Oct; 80(10):1135-42. PubMed ID: 24326971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aminoglygoside nephrotoxicity].
    Baykal M
    Mikrobiyol Bul; 1986 Jan; 20(1):32-6. PubMed ID: 3523171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial aminoglycoside levels in the critically ill.
    Summer WR; Michael JR; Lipsky JJ
    Crit Care Med; 1983 Dec; 11(12):948-50. PubMed ID: 6641254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring aminoglycoside level.
    Banerjee S; Narayanan M; Gould K
    BMJ; 2012 Sep; 345():e6354. PubMed ID: 23044986
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.